Crispr Therapeutics

Yahoo Finance • 4 days ago

Interesting CRSP Put And Call Options For November 7th

Investors in CRISPR Therapeutics AG (Symbol: CRSP) saw new options begin trading today, for the November 7th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the CRSP options chain for the new November... Full story

Yahoo Finance • 7 days ago

CRISPR Therapeutics and Sirius Therapeutics Announce First Patient Dosed in Phase 2 Trial of SRSD107 for Thromboembolic Disorders in Europe

ZUG, Switzerland and BOSTON and SAN DIEGO and SHANGHAI, Sept. 22, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (NASDAQ: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and... Full story

Yahoo Finance • 11 days ago

CRISPR Therapeutics wins new Overweight rating at J.P. Morgan on pipeline prospects

[Business on Wall Street in Manhattan] Pgiam/iStock via Getty Images CRISPR Therapeutics (NASDAQ:CRSP [https://seekingalpha.com/symbol/CRSP]) traded higher in the premarket on Thursday after J.P. Morgan initiated its coverage with an Over... Full story

Yahoo Finance • 11 days ago

Global Cell Therapy Market Size Expected to Reach $44 Billion as Demand for Regenerative Medicine Rises

MarketNewsUpdates News Commentary NEW YORK, Sept. 18, 2025 /PRNewswire/ -- Cell therapy refers to a treatment that involves the use of living cells to treat diseases. The cell therapy market has been experiencing significant growth due to... Full story

Yahoo Finance • 20 days ago

CRISPR Therapeutics to Present Late-Breaking Data at the American Heart Association (AHA) Scientific Sessions 2025

ZUG, Switzerland and BOSTON, Sept. 09, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that a late-bre... Full story

Yahoo Finance • 29 days ago

Large-cap biotech is a sector to watch for investors: Analysts

Wall Street is looking for new ways to park cash in healthcare names, and large-cap biotechs have begun to gain steam. This asset class differs from traditional large-cap pharmaceutical companies — typically with a $200 billion market cap... Full story

Yahoo Finance • last month

Cathie Wood's ARK buys CRISPR, sells Roku and DraftKings stock

Cathie Wood’s ARK ETFs have reported their daily trades for Tuesday, August 26th, 2025, with significant activity in biotech and tech stocks. The largest trade of the day was the purchase of 165,874 shares of CRISPR THERAPEUTICS AG (NASDAQ... Full story

Yahoo Finance • last month

Cathie Wood's ARK shifts focus, buys CRSP stock, sells ROKU

Cathie Wood’s ARK ETF released their daily trades for Monday, August 25th, 2025, revealing a significant reshuffle in their portfolio. The firm’s largest transaction involved selling 141,194 shares of Roku Inc (NASDAQ:ROKU), amounting to a... Full story

Yahoo Finance • last month

CRISPR Therapeutics (CRSP) Reports Increase In Q2 Revenue Despite Wider Net Losses

CRISPR Therapeutics recently reported second-quarter results with a significant year-over-year increase in revenue, although net losses also widened. The company's addition to multiple Russell Indices on June 30, 2025, likely buoyed invest... Full story

Yahoo Finance • last month

BC-Most Active Stocks

NEW YORK (AP) — prices for the Nasdaq composite, NYSE and NYSE American listed most active stocks. Nasdaq most active stocks: Stock Name Volume High Low Last Change Color Star Technology Co. Ltd. 254,314,419 0.131 0.1142 0.1188 +0.0291 O... Full story

Yahoo Finance • last month

Cathie Wood's ARK ETF bolsters biotech, trims defense stock

Cathie Wood’s ARK ETF published their daily trades for Monday, August 18th, 2025, showcasing a continued focus on the biotech sector while reducing exposure in defense. The largest trade of the day was the purchase of 170,471 shares of Gen... Full story

Yahoo Finance • last month

What Makes Crispr Therapeutics Ag (CRSP) a Good Buy?

RGA Investment Advisors, an investment management company, has released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. The second quarter-end figures concealed the inherent volatility in the market, w... Full story

Yahoo Finance • last month

Cathie Wood's ARK ETF focuses on Roblox and CoreWeave stock buys

Cathie Wood’s ARK ETF released its daily trades for Friday, August 15th, 2025, revealing a series of strategic investments and divestments across various sectors. The largest transaction of the day was the purchase of 125,799 shares of Rob... Full story

Yahoo Finance • 2 months ago

Which Gene Therapy Technology Wins? New Data from Spherix Global Insights Reveals Emerging Hematologist Preferences in Beta Thalassemia Care

EXTON, PA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- As the first wave of gene therapies for transfusion-dependent β-thalassemia (TDT) continues to roll out in the U.S., a new conversation is emerging within the hematology community: whether the... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK makes major moves in Trade Desk and Block stock

Cathie Wood’s ARK ETFs have once again made significant trades on Tuesday, 12 August 2025, with a major focus on tech and biotech stocks. The most substantial trade of the day was the purchase of 738,367 shares of Trade Desk Inc (NASDAQ:... Full story

Yahoo Finance • 2 months ago

Benjamin Graham Detailed Fundamental Analysis - CRSP

Below is Validea's guru fundamental report for CRISPR THERAPEUTICS AG (CRSP). Of the 22 guru strategies we follow, CRSP rates highest using our Value Investor model based on the published strategy of Benjamin Graham. This deep value metho... Full story

Yahoo Finance • 2 months ago

Cathie Wood's ARK ETF adjusts portfolio with AMD and NVDA stock buys

Cathie Wood’s ARK ETFs have published their daily trades for Monday, August 4th, 2025, reflecting a mix of strategic buys and sells across various sectors. Leading the day’s activity was a significant sell-off of Roblox Corp (PRE-REINCOR... Full story

Yahoo Finance • 2 months ago

CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

-CASGEVY® momentum building; >75 authorized treatment centers (ATCs) activated globally, achieving the target goal and ~115 patients have had cells collected across all regions; positioning the program for strong future growth- -Clinical... Full story

Yahoo Finance • 2 months ago

3 Unstoppable Stocks to Buy in August

What are the best stocks? Usually, the ones that have clear paths to success. Three Motley Fool contributors have identified what they believe are unstoppable stocks to buy in August. And they all happen to be biotech and pharma companies... Full story

Yahoo Finance • 2 months ago

Cathie Wood Loads Up Millions on Google, AMD in Bold ARK Shift

July 29 - Cathie Wood's ARK ETFs tweaked their portfolios Monday, rotating into tech and biotech names as they fine?tune sector exposure. The biggest addition came in ARKW, where ARK bought 181,640 shares of Alphabet (NASDAQ:GOOG) for rou... Full story